Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double‐blind placebo‐controlled trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2133|172|3|754-759

ISSN: 0007-0963

Source: BRITISH JOURNAL OF DERMATOLOGY, Vol.172, Iss.3, 2015-03, pp. : 754-759

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract